Zdrowie i gospodarka · 10/05/2019

FDA Announces Final Guidance on Reproductive Toxicity Testing for Oncology Pharmaceuticals

The FDA has released a final guidance to help pharmaceutical companies evaluate reproductive toxicity in anticancer medications and provide labeling recommendations to minimize risks to developing embryos or fetuses, aiming to balance animal welfare with the development of effective treatments.